Reimbursement and Pricing
Stefan Walzer (),
Roman Spelsberg () and
Lutz Vollmer ()
Additional contact information
Stefan Walzer: MArS Market Access & Pricing Strategy GmbH
Roman Spelsberg: MArS Market Access & Pricing Strategy GmbH
Lutz Vollmer: MArS Market Access & Pricing Strategy GmbH
A chapter in Digital Healthcare in Germany, 2022, pp 69-83 from Springer
Abstract:
Abstract The price is a driver for the profitability of a digital health application and can be set in a cost-oriented, value-added and strategic manner in the secondary health market. As a rule, a larger number of units might be linked to a lower price. The pricing should take into account the relatively low willingness of patients in Germany to buy, as it is expected that health insurance costs will be financed by the health insurance company. For price assessments by statutory health insurances in the primary health market, cost-based surcharges are relevant when determining new reimbursement rates, as well as savings in existing care. In addition, value-based surcharges for digital health solutions according to the DIGA law and strategic considerations are taken into account in pricing. From the seller’s point of view, it is important that a price is value-oriented and that the product can be quickly available on the market.
Date: 2022
References: Add references at CitEc
Citations:
There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:spr:conchp:978-3-030-94025-6_7
Ordering information: This item can be ordered from
http://www.springer.com/9783030940256
DOI: 10.1007/978-3-030-94025-6_7
Access Statistics for this chapter
More chapters in Contributions to Economics from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().